Exact Mass: 904.3827472

Exact Mass Matches: 904.3827472

Found 12 metabolites which its exact mass value is equals to given mass value 904.3827472, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

L-Tryptophan, N-(N(2)-(N-(N-(N-L-methionyl-L-alpha-glutamyl)-L-histidyl)-L-phenylalanyl)-L-arginyl)-

4-[2-amino-4-(methylsulfanyl)butanamido]-4-{[1-({1-[(1-{[1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-4-[(diaminomethylidene)amino]butyl)carbamoyl]-2-phenylethyl}carbamoyl)-2-(3H-imidazol-4-yl)ethyl]carbamoyl}butanoic acid

C42H56N12O9S (904.4013726000001)


   
   
   

hedyotol C 4,4-di-O-beta-D-glucopyranoside

hedyotol C 4,4-di-O-beta-D-glucopyranoside

C45H60O19 (904.3728610000001)


   
   

L-Tryptophan, N-(N(2)-(N-(N-(N-L-methionyl-L-alpha-glutamyl)-L-histidyl)-L-phenylalanyl)-L-arginyl)-

4-[2-amino-4-(methylsulfanyl)butanamido]-4-{[1-({1-[(1-{[1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-4-[(diaminomethylidene)amino]butyl)carbamoyl]-2-phenylethyl}carbamoyl)-2-(3H-imidazol-4-yl)ethyl]carbamoyl}butanoic acid

C42H56N12O9S (904.4013726000001)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

dimethyl 2-[3-[(3S,3S,4R,6S,8R,8aR)-6-[2-(2-hydroxyethoxy)phenyl]-1,2-dioxo-3,4-diphenyl-8-(4-pyrimidin-2-ylpiperazine-1-carbonyl)spiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]-5-yl]prop-2-ynyl]propanedioate

dimethyl 2-[3-[(3S,3S,4R,6S,8R,8aR)-6-[2-(2-hydroxyethoxy)phenyl]-1,2-dioxo-3,4-diphenyl-8-(4-pyrimidin-2-ylpiperazine-1-carbonyl)spiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]-5-yl]prop-2-ynyl]propanedioate

C51H48N6O10 (904.3431748)


   

Chromium triacetylfusarinin C [M+Cr-2H]

Chromium triacetylfusarinin C [M+Cr-2H]

C39H60CrN6O15 (904.352155)


   
   
   

Relamorelin (TFA)

Relamorelin (TFA)

C45H51F3N8O7S (904.3553331999999)


Relamorelin (RM-131) TFA, a pentapeptide ghrelin analog, is a selective ghrelin/growth hormone secretagogue receptor (GHSR) agonist with a Ki of 0.42 nM for GHS-1a receptor. Relamorelin TFA is centrally penetrant. Relamorelin TFA increases growth hormone levels and accelerates gastric emptying. Relamorelin TFA has the potential for cachexia, gastroparesis, and gastric/intestinal dysmobility disorders research[1][2][3][4][5].